Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolff

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patientsJ P Greer, W R Macon, R E Lamar, et al.
Antioxidants & Redox Signaling|March 10, 2001
Oxidative stress and NF-kappaB activation: correlation in patients following allogeneic bone marrow transplantationT S Blackwell, J W Christman, T Hagan, et al.
The Annals of Thoracic Surgery|December 1, 1984
The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluationR L Prager, J M Foster, J D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphomaJ P Greer, M C Kinney, R D Collins, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 23, 2022
Cancer-related somatic mutations alter adenosine A<sub>1</sub> receptor pharmacology-A focus on mutations in the loops and C-terminusXuesong Wang, Willem Jespers, Just J de Waal, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patientsJ P Greer, W R Macon, R E Lamar, et al.
Antioxidants & Redox Signaling|March 10, 2001
Oxidative stress and NF-kappaB activation: correlation in patients following allogeneic bone marrow transplantationT S Blackwell, J W Christman, T Hagan, et al.
The Annals of Thoracic Surgery|December 1, 1984
The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluationR L Prager, J M Foster, J D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphomaJ P Greer, M C Kinney, R D Collins, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 23, 2022
Cancer-related somatic mutations alter adenosine A<sub>1</sub> receptor pharmacology-A focus on mutations in the loops and C-terminusXuesong Wang, Willem Jespers, Just J de Waal, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Pageof 18